{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:34:21Z","timestamp":1773318861089,"version":"3.50.1"},"reference-count":113,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:p>This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ntiviral <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>roup <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>onference \u2010 advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel\/pre\u2010licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non\u2010influenza respiratory viruses such as <jats:styled-content style=\"fixed-case\">MERS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>o<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>, respiratory syncytial virus (<jats:styled-content style=\"fixed-case\">RSV<\/jats:styled-content>) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.<\/jats:p>","DOI":"10.1111\/irv.12293","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T11:33:57Z","timestamp":1416051237000},"page":"20-31","source":"Crossref","is-referenced-by-count":15,"title":["Overview of the 3rd isirv\u2010Antiviral Group Conference \u2013 advances in clinical management"],"prefix":"10.1111","volume":"9","author":[{"given":"Aeron C.","family":"Hurt","sequence":"first","affiliation":[{"name":"WHO Collaborating Centre for Reference and Research on Influenza VIDRL at the Peter Doherty Institute for Infection and Immunity Parkville Vic. Australia"},{"name":"Melbourne School of Population and Global Health University of Melbourne Parkville Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Medicine &amp; Therapeutics The Chinese University of Hong Kong Shatin Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Hay","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research Mill Hill London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick G.","family":"Hayden","sequence":"additional","affiliation":[{"name":"School of Medicine University of Virginia Charlottesville VA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Programme of the third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan. Available at:http:\/\/www.isirv.org\/site\/images\/stories\/avg\/documents\/intranet\/Tokyo\/programe_abstract_book.pdf(Accessed 1 September 2014). Website 2014."},{"key":"e_1_2_6_3_1","unstructured":"CDC.Influenza Risk Assessment Tool (IRAT). Available at:http:\/\/www.cdc.gov\/flu\/pandemic-resources\/tools\/risk-assessment.htm(Accessed 1 September 2014). Website 2014."},{"key":"e_1_2_6_4_1","unstructured":"WHO.Overview of the emergence and characteristics of the avian influenza A(H7N9) virus. Available at:http:\/\/www.who.int\/influenza\/human_animal_interface\/influenza_h7n9\/WHO_H7N9_review_31May13.pdf(Accessed 1 September 2014). Website 2013."},{"key":"e_1_2_6_5_1","unstructured":"WHO.Confirmed human cases of avian influenza A(H7N9) reported to WHO. Available at:http:\/\/www.who.int\/influenza\/human_animal_interface\/influenza_h7n9\/17_ReportWebH7N9Number_20140408.pdf?ua=1(Accessed 1 September 2014). Website 2014."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305584"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61904-2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1305865"},{"key":"e_1_2_6_9_1","unstructured":"ShuY.H7N9 in China: Virologic and Epidemiologic Features. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation PS1\u20132."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12379"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep03058"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00006414"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61125-3"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3854"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu353"},{"key":"e_1_2_6_16_1","unstructured":"RithS HormSV SokTet\u00a0al.Molecular Epidemiology of Influenza A\/H5N1 Clade 1 circulation in Cambodia. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation O2."},{"key":"e_1_2_6_17_1","unstructured":"WHO.Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO 2003\u20132014. Available athttp:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20140124CumulativeNumberH5N1cases.pdf. Website 2014."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1505.080316"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029971"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/656316"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis509"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091630"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707279"},{"key":"e_1_2_6_24_1","unstructured":"WHO Representative Office China.WHO China statement on H5N6. Available athttp:\/\/www.wpro.who.int\/china\/mediacentre\/releases\/2014\/20140507\/en\/. Website 2014."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60111-2"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.01.002"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2011.01812.x"},{"key":"e_1_2_6_28_1","unstructured":"ChawL BurmaaA KamigakiTet\u00a0al.Epidemiology of influenza infection among pregnant women and childrn under 6\u00a0months in Mongolia 2013\/14 Season: A prospective Cohort Study. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation O4."},{"key":"e_1_2_6_29_1","unstructured":"DarL KumarR SinghYet\u00a0al.Influenza viruses in children from a rural indian community: a post\u2010pandemic surveillance study. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P56."},{"key":"e_1_2_6_30_1","first-page":"461","article-title":"Vaccines against influenza WHO position paper \u2013 November 2012","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_6_31_1","unstructured":"VirkRK GunalanV TanBHet\u00a0al.Molecular evidence of transmission of influenza on a university campus in Singapore. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P31."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2922"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-011-0288-0"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/589748"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/509925"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12147"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70041-4"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0622-9"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku146"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181de9d24"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.1.20666"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1111078"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis337"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004065"},{"key":"e_1_2_6_45_1","unstructured":"YatesPJ MehtaN HasanSet\u00a0al.Identification of resistance mutations as minority species in clinical specimens from hospitalised adults with influenza and treated with intravenous zanamivir. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P19."},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02628-13"},{"key":"e_1_2_6_47_1","unstructured":"FurukawaH MurayamaM SoutomeTet\u00a0al.Safety and efficacy of intravenous zanamivir in the treatment of hospitalised Japanese patients with influenza infection. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P34."},{"key":"e_1_2_6_48_1","unstructured":"KirillovaES GaraevTM ShibnevVAet\u00a0al.New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm09 and A(H3N2) viruses to rimantadine. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P18."},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.13.98"},{"key":"e_1_2_6_50_1","unstructured":"TrevejoJ DengR BurgessTet\u00a0al.Safety and efficacy of MHAA4549A a novel monoclonal antibody for treatment of severe influenza A. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation O8."},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092822"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.038679-0"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu105"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis622"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404205111"},{"key":"e_1_2_6_56_1","unstructured":"GovorkovaEA ConnarisH TaylorMAet\u00a0al.Prevention of lethal H7N9 influenza virus infection by a novel receptor\u2010binding protein. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation O14."},{"key":"e_1_2_6_57_1","unstructured":"SinganayagamA CockingR MoncorgeOet\u00a0al.2009 pandemic H1N1 influenza can rapidly develop escape mutations in the presence of a host\u2010directed vacuolar ATPase inhibiting drug. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P39."},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.6.20701"},{"key":"e_1_2_6_59_1","unstructured":"ShinjohM SekiguchiS IwataSet\u00a0al.Estimated effectiveness of influenza vaccine using influenza rapid diagnostic tests \u2013 test\u2010negative case\u2010control study among Japanese Children. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation P10."},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12245"},{"key":"e_1_2_6_61_1","first-page":"i","article-title":"Fluzone high\u2010dose vaccine is significantly more effective than the standard dose of fluzone vaccine in preventing influenza in adults \u226565\u00a0years of age","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"e_1_2_6_62_1","unstructured":"KawaokaY.Current progress in influenza research. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation ES."},{"key":"e_1_2_6_63_1","unstructured":"WHO.Middle East respiratory syndrome coronavirus (MERS\u2010CoV) \u2013 update Disease outbreak news 14 July 2014. Available athttp:\/\/www.who.int\/csr\/don\/2014_07_14_mers\/en\/. Website 2014."},{"key":"e_1_2_6_64_1","unstructured":"WHO.Middle East respiratory syndrome coronavirus (MERS\u2010CoV) summary and literature update\u2013as of 11 June 2014. Available athttp:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/MERS-CoV_summary_update_20140611.pdf?ua=1. Website 2014."},{"key":"e_1_2_6_65_1","unstructured":"Public Health England\/ISARIC.Treatment of MERS\u2010CoV: Information for Clinicians Clinical decision\u2010making support for treatment of MERS\u2010CoV patients. Available athttp:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1317139281416. Website 2014."},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00884-14"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70304-9"},{"key":"e_1_2_6_68_1","unstructured":"ZambonM.MERS\u2010CoV situation update. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation PS1\u20104."},{"key":"e_1_2_6_69_1","unstructured":"GalianoM MyersR FariaNRet\u00a0al.Inferring intra\u2010and inter\u2010host MERS\u2010CoV evolutionary dynamics in a transmission chain by deep whole genome sequencing. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation O1."},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.09.008"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.09.029"},{"key":"e_1_2_6_72_1","first-page":"jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta\u2010analysis","author":"Mair\u2010Jenkins J","year":"2014","journal-title":"J Infect Dis"},{"key":"e_1_2_6_73_1","unstructured":"PHE\/ISARIC.Treatment of MERS\u2010CoV:Decision Support Tool Clinical\u00a0Decision Making Tool for Treatment of MERS\u2010CoV v.1.1 29 July 2013;https:\/\/isaric.tghn.org\/site_media\/media\/articles\/Decision_Support_Document_v1_1_20130729.pdf. Website 2014."},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000187274.48387.42"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit471"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211917"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000240"},{"key":"e_1_2_6_80_1","unstructured":"KimuraH TsukagoshiH RyoAet\u00a0al.Molecular Epidemiology of Human Rhinovirus (HRV) in Patients with Asthma. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation PS6\u20102."},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2235OC"},{"key":"e_1_2_6_82_1","unstructured":"MatzJ.Vapendavir for The Treatment Of Naturally Acquired Rhinovirus Infection In Asthmatic Adults: Effect On Asthma Control In A Phase 2 Clinical Trial. American Thoracic Society Conference 2013 2013; Poster Board # C17; Publication Page: A5497."},{"key":"e_1_2_6_83_1","unstructured":"JenningsL.Advances in diagnostics for influenza and RVI's. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management Third isirv\u2010Antiviral Group Conference June 4\u20136 2014 Tokyo Japan 2014; Presentation PS3\u20101."},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02787-13"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.07.014"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70717-0"},{"key":"e_1_2_6_87_1","unstructured":"RossignolJF.Nitazoxanide: A new broad spectrum antiviral agent against respiratory virus efficacy resistance and mechnaism of action. 9th Australian Influenza Symposium 3\u20104 October 2013 Sydney Australia 2014; D2.P4."},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12171"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.07.006"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.815"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.5023"},{"key":"e_1_2_6_92_1","first-page":"CD004878","article-title":"Glucocorticoids for acute viral bronchiolitis in infants and young children","volume":"6","author":"Fernandes RM","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203581"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit725"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283480440"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis610"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.09.014"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181ff863b"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70133-X"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319186"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.12"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12116"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2475"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00582.x"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1086\/652655"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.11.575"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12045"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12177"},{"key":"e_1_2_6_109_1","unstructured":"WaghmareA WagnerT AndrewsRet\u00a0al.Successful treatment of parainfluenza virus (PIV) respiratory infection with DAS181 in 3 immunocompromised children. ID Week 2013 October 2\u20136 2013 San Francisco USA 2013; Presentation 472."},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0422OC"},{"key":"e_1_2_6_111_1","unstructured":"SimonA KarstemnV CehelskyJet\u00a0al.Results of a phase 2b multi\u2010center trial of ALN\u2010RSV01 in respiratory syncytial virus (RSV)\u2010infected lung transplant patients. European Respiratory Society Vienna 2012 2012; Presentation P1476."},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1165-x"},{"key":"e_1_2_6_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303688"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.09.007"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Firv.12293","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.12293","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:27:56Z","timestamp":1695497276000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.12293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/irv.12293"],"URL":"https:\/\/doi.org\/10.1111\/irv.12293","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}